U.S., July 9 -- An application to own the trademark for 'TULVEGIO RIVOCERANIB' has been filed on Aug. 13, 2024.
Owner(s):
Elevar Therapeutics, Inc.; 2825 East Cottonwood Parkway, Suite 180, , UTAH
Goods and/or Services:
For: Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Development of therapeutics in the nature of pharmaceutical preparations for the treatment of cancer containing rivoceranib
Class(es): 100, 101
Mark Drawing Type: 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)
https://eog-tmng.uspto.gov/#/issueDate=2025-07-08&serialNumber=98695795
Disclaimer: Curated by HT Syndication....